276 related articles for article (PubMed ID: 34081788)
1. Does autoimmune vitiligo protect against COVID-19 disease?
Post NF; Luiten RM; Wolkerstorfer A; Bekkenk MW; Böhm M
Exp Dermatol; 2021 Sep; 30(9):1254-1257. PubMed ID: 34081788
[TBL] [Abstract][Full Text] [Related]
2. [The role of HLA genes: from autoimmune diseases to COVID-19].
Troshina EA; Yukina MY; Nuralieva NF; Mokrysheva NG
Probl Endokrinol (Mosk); 2020 Sep; 66(4):9-15. PubMed ID: 33351354
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea.
Kim HJ; Kim MH; Park SJ; Choi MG; Chun EM
J Allergy Clin Immunol; 2024 Jun; 153(6):1711-1720. PubMed ID: 38520423
[TBL] [Abstract][Full Text] [Related]
4. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
5. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
Basak P; Sachdeva N; Dayal D
Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population.
Yun JY; Uhm YK; Kim HJ; Lim SH; Chung JH; Shin MK; Yim SV; Lee MH
Int J Immunogenet; 2010 Aug; 37(4):289-91. PubMed ID: 20518838
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 triggering autoimmune diseases.
Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
[TBL] [Abstract][Full Text] [Related]
8. Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.
Opdenakker G; Van Damme J
Cytokine Growth Factor Rev; 2021 Apr; 58():134-140. PubMed ID: 33563543
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
10. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
11. Lessons from dermatology about inflammatory responses in Covid-19.
Criado PR; Pagliari C; Carneiro FRO; Quaresma JAS
Rev Med Virol; 2020 Sep; 30(5):e2130. PubMed ID: 32656939
[TBL] [Abstract][Full Text] [Related]
12. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
14. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.
Grolmusz VK; Bozsik A; Papp J; Patócs A
Front Immunol; 2021; 12():653489. PubMed ID: 33763088
[TBL] [Abstract][Full Text] [Related]
15. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.
Spritz RA
Thyroid; 2010 Jul; 20(7):745-54. PubMed ID: 20578892
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
17. Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.
Liu BM; Hill HR
J Interferon Cytokine Res; 2020 Dec; 40(12):549-554. PubMed ID: 33337932
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
19. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]